Fermenta Biotech LTD.

Fermenta Biotech Ltd. (FERMENTA) is a micro-cap Healthcare company valued at ₹1,430 crore operating in Pharmaceuticals on the NSE and BSE.

Recent price move

Fermenta Biotech Ltd. last traded at ₹487.5, modestly up 0.21% on the day.

Recent developments

On 2026-08-05, the company announced a dividend of ₹3.75 per share, ex-date. The latest quarter results showed a significant decline in net profit compared to the same period last year, raising questions about recent operational performance.

Financial performance

The company's annual revenue rose 11.8% to ₹523 crore, but net profit fell 7.9% to ₹70 crore. The latest quarter saw revenue drop 10.6% year-on-year to ₹122 crore, and net profit plunged 55.9% to ₹10 crore, indicating a slowdown in recent performance.

Valuation multiples

The stock trades at 20.0 times earnings, a discount to the Healthcare median of 32.0, 2.55 times book value. It yields 0.8%.

Things to watch

The company's net profit margin narrowed 2.9 percentage points to 13.4%, and the latest quarter's net profit fell sharply by 55.9%. The stock is 4.7% below its 52-week high, and the company's net profit has swung from a loss to profit over the past three years, showing volatility.

Where it stands

Fermenta Biotech Ltd's annual revenue grew 11.8% but net profit declined 7.9%, with the latest quarter showing a sharp drop in both revenue and net profit. The stock is 4.7% below its 52-week high, and the company's net profit margin has narrowed, highlighting recent challenges in profitability.

Summarised by DocStoX's model on 2026-10-04 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.